Intestinal microbiota and its functions

Digestive and Liver Disease Supplements

Volumn 3, Issue 2, 2009, Pages 30-34

  Montalto, M ^a   D'Onofrio, F ^a   Gallo, A ^a   Cazzato, A ^a   Gasbarrini, G ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Gut; Intestinal mucosa; Metabolism; Microbiota

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL METABOLISM; COLON; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE FUNCTION; MICROVILLUS; NONHUMAN; PRIORITY JOURNAL;

EID: 67650388772     PISSN: 15945804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1594-5804(09)60016-4     Document Type: Article

References (55)

1. Hooper L.V., Midtvedt T., and Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002) 283-307
2. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
3. Gustafsson B.E. The physiological importance of the colonic microflora. Scand J Gastroenterol Suppl 77 (1982) 117-131
4. Suau A., Bonnet R., Sutren M., et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65 (1999) 4799-4807
5. Noverr M.C., and Huffnagle G.B. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol 12 (2004) 562-568
6. Blaut M., and Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137 (2007) 751-755
7. Schiffrin E.J., and Blum S. Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 56 (2002) S60-S64
8. Bouhnik Y., Vahedi K., Achour L., et al. Short-chain fructooligosac-charide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 129 (1999) 113-116
9. Backhed F., Ley R.E., Sonnenburg J.L., et al. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
10. Xu J., Mahowald M.A., Ley R.E., et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 5 (2007) e156
11. Turnbaugh P.J., Ley R.E., Mahowald M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
12. O'Hara A.M., and Shanahan F. The gut flora as a forgotten organ. EMBO Rep 7 (2006) 688-693
13. Nicholson J.K., Holmes E., and Wilson I.D. Gut microorganisms, mammalian metabolism and personalized healthcare. Nat Rev Microbiol 3 (2005) 431-438
14. Cebra J.J. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69 (1999) 1046S-1051S
15. Wostmann B.S. The germfree animal in nutritional studies. Annu Rev Nutr 1 (1981) 257-279
16. Macpherson A.J., and Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004) 478-485
17. Salzman N.H., Underwood M.A., and Bevins C.L. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 19 (2007) 70-83
18. Didierlaurent A., Sirard J.C., Kraehenbuhl J.P., et al. How the gut senses its content. Cell Microbiol 4 (2002) 61-72
19. Hooper L.V., Wong M.H., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
20. Lehrer R.I., Bevins C.L., and Ganz T. Defensins and other antimicrobial peptides. In: Mestecky J., Bienstock J., Lamm M.E., Strober W.M., McGhee J., and Mayer L. (Eds). Mucosal immunology. 3rd ed. (2004), Academic Press, New York 95-110
21. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11 (1993) 105-128
22. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
23. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18 (2000) 621-663
24. Kaisho T., and Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 3 (2003) 373-385
25. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nature Rev Immunol 3 (2003) 371-382
26. Kim J.G., Lee S.J., and Kagnoff M.F. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect Immun 72 (2004) 1487-1495
27. Rescigno M., Urbano M., Valzasina B., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 (2001) 361-367
28. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 189 (1999) 447-450
29. Fanaro S., Chierici R., Guerrini P., et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91 (2003) 48-55
30. Hopkins M.J., Sharp R., and Macfarlane G.T. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acids profile. Gut 48 (2001) 198-205
31. Zocco M.A., Ainora M.E., Gasbarrini G., et al. Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis 39 (2007) 707-712
32. Cummings J.H., and Macfarlane G.T. Colonic microflora: nutrition and health. Nutrition 13 (1997) 476-478
33. Macfarlane S., and Macfarlane G.T. Proteolysis and amino acid fermentation. In: Gibson G.R., and Macfarlane G.T. (Eds). Human colonic bacteria: role in nutrition, physiology and pathology (1995), CRC Press, Boca Raton 75-100
34. Roediger W.E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21 (1980) 793-798
35. Harig J.M., Soergel K.H., Komorowski R.A., et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 320 (1989) 23-28
36. Segain J.P., Raingeard de la Bletiere D., Bourreille A., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 (2000) 397-403
37. Luhrs H., Gerke T., Muller J.G., et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37 (2002) 458-466
38. Allison M.J., Dawson K.A., Mayberry W.R., et al. Oxalobacter formigenes gen. nov., sp. nov.: Oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141 (1985) 1-7
39. Sidhu H., Schmidt M.E., Cornelius J.G., et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 (1999) S334-S340
40. Birt D.F., Hendrich S., and Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90 (2001) 157-177
41. Adlercreutz H., and Mazur W. Phyto-oestrogens and Western diseases. Ann Med 29 (1997) 95-120
42. Kahn S.E., Hull R.L., and Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846
43. Tappy L. Metabolic consequences of overfeeding in humans. Curr Opin Clin Nutr Metab Care 7 (2004) 623-628
44. Levin B.E., and Keesey R.E. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 274 (1998) R412-R419
45. Ley R.E., Turnbaugh P.J., Klein S., et al. Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006) 1022-1023
46. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 (2004) 15718-15723
47. Ley R.E., Backhed F., Turnbaugh P., et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102 (2005) 11070-11075
48. Clinton S.K., Bostwick D.G., Olson L.M., et al. Effects of ammonium acetate and sodium cholate on N-methyl-N′-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res 48 (1988) 3035-3039
49. Magee E.A., Richardson C.J., Hughes R., et al. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 72 (2000) 1488-1494
50. Hecht S.S. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med 216 (1997) 181-191
51. Bone E., Tamm A., and Hill M. The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 29 (1976) 1448-1454
52. McGarr S.E., Ridlon J.M., and Hylemon P.B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol 39 (2005) 98-109
53. Reddy B.S. Diet and excretion of bile acids. Cancer Res 41 (1981) 3766-3768
54. Nagengast F.M., Grubben M.J., and Van Munster I.P. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31A (1995) 1067-1070
55. McBain A.J., and Macfarlane G.T. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 47 (1998) 407-416